Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Hypermethylated genes targeted by decitabine in MDS

Nov. 22, 2002

AlphaRx to sublicense cancer therapeutic from Select Therapeutics

Nov. 22, 2002

Oxi-4503 compares favorably to CA4P in antivascular and antitumor activity

Nov. 21, 2002

Antitumor activity and resistance mechanisms further characterized for XR-5944 and XR-11576

Nov. 21, 2002

Phase I data for NB-1011 discussed at EORTC-NCI-AACR symposium

Nov. 21, 2002

Aventis scientists present new tubulin polymerization inhibitors

Nov. 21, 2002

Phase I/II trial initiated for LE-SN-38

Nov. 20, 2002

Preclinical and early clinical data discussed for OSI-7836 in Frankfurt

Nov. 20, 2002

FDA approves SuperGen's NDA to market Mitozytrex

Nov. 20, 2002

D-63153, a new GnRH antagonist as a candidate for sex steroid-dependent diseases

Nov. 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...